Moderna | MRNA - Current Liabilities



Moderna reported $1.57B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Acadia Pharmaceuticals USD 330.02M 27.49M Jun/2025
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Agios Pharmaceuticals USD 70.41M 18.04M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Amgen USD 20.48B 2.53B Jun/2025
Arrowhead Research USD 194.53M 26.01M Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
BioMarin Pharmaceutical USD 684.25M 56.03M Jun/2025
Celltrion KRW 3.4T 216.25B Mar/2025
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 1.57B 32M Jun/2025
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pharma Mar EUR 87.78M 8.29M Jun/2025
Qiagen NV USD 1.13B 611.37M Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Tilray USD 278.52M 15.02M Nov/2024
Ultragenyx Pharmaceutical USD 293.24M 1.58M Jun/2025
United Therapeutics USD 527.1M 194.4M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025